Search research articles
Contact Us
Filters
Showing results (71-80 of 380) with videos related to
Page
of 38
Sort By:
Zeitschrift Fur Rheumatologie
|
March 21, 2007
[Autoantibody profile in rheumatoid arthritis]
E Feist, K Egerer, G-R Burmester
Zeitschrift Fur Rheumatologie
|
March 27, 2001
[The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences]
S Bläss, J M Engel, G R Burmester
The American Journal of Medicine
|
February 15, 2001
Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors
F Buttgereit, G R Burmester, L S Simon
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1994
Basic mechanisms in rheumatoid arthritis: the role of T lymphocytes in rheumatoid synovitis
S Alsalameh, G R Burmester, J R Kalden
Clinical and Experimental Rheumatology
|
October 14, 2009
Analyses of similarities and differences in glucocorticoid therapy between rheumatoid arthritis and ankylosing spondylitis - a systematic comparison
C M Spies, G-R Burmester, F Buttgereit
Zeitschrift Fur Rheumatologie
|
November 1, 1991
[The role of cytokines and growth factors in rheumatoid joint destruction]
S Alsalameh, J R Kalden, G R Burmester
Clinical and Experimental Rheumatology
|
November 4, 2010
Methotrexate treatment in large vessel vasculitis and polymyalgia rheumatica
C M Spies, G-R Burmester, F Buttgereit
Annals of the Rheumatic Diseases
|
August 15, 2006
Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis
H U Scherer, G-R Burmester, G Riemekasten
Zeitschrift Fur Rheumatologie
|
December 11, 2012
[Biomarkers and personalized medicine]
H U Scherer, G-R Burmester, T Häupl
Biochemical Pharmacology
|
July 28, 1999
Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy
F Buttgereit, M D Brand, G R Burmester
Page
of 38
Search research articles
Search
Showing results (71-80 of 380) with videos related to
Sort By:
Page
of 38
Zeitschrift Fur Rheumatologie
|
March 21, 2007
[Autoantibody profile in rheumatoid arthritis]
E Feist, K Egerer, G-R Burmester
Zeitschrift Fur Rheumatologie
|
March 27, 2001
[The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences]
S Bläss, J M Engel, G R Burmester
The American Journal of Medicine
|
February 15, 2001
Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors
F Buttgereit, G R Burmester, L S Simon
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1994
Basic mechanisms in rheumatoid arthritis: the role of T lymphocytes in rheumatoid synovitis
S Alsalameh, G R Burmester, J R Kalden
Clinical and Experimental Rheumatology
|
October 14, 2009
Analyses of similarities and differences in glucocorticoid therapy between rheumatoid arthritis and ankylosing spondylitis - a systematic comparison
C M Spies, G-R Burmester, F Buttgereit
Zeitschrift Fur Rheumatologie
|
November 1, 1991
[The role of cytokines and growth factors in rheumatoid joint destruction]
S Alsalameh, J R Kalden, G R Burmester
Clinical and Experimental Rheumatology
|
November 4, 2010
Methotrexate treatment in large vessel vasculitis and polymyalgia rheumatica
C M Spies, G-R Burmester, F Buttgereit
Annals of the Rheumatic Diseases
|
August 15, 2006
Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis
H U Scherer, G-R Burmester, G Riemekasten
Zeitschrift Fur Rheumatologie
|
December 11, 2012
[Biomarkers and personalized medicine]
H U Scherer, G-R Burmester, T Häupl
Biochemical Pharmacology
|
July 28, 1999
Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy
F Buttgereit, M D Brand, G R Burmester
Page
of 38